Barclays’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $517K | Buy |
214,885
+60,631
| +39% | +$146K | ﹤0.01% | 3024 |
|
|
2025
Q1 | $340K | Sell |
154,254
-53,038
| -26% | -$117K | ﹤0.01% | 3062 |
|
|
2024
Q4 | $1.13M | Buy |
207,292
+23,103
| +13% | +$126K | ﹤0.01% | 2562 |
|
|
2024
Q3 | $1.53M | Buy |
184,189
+143,184
| +349% | +$1.19M | ﹤0.01% | 2366 |
|
|
2024
Q2 | $294K | Buy |
41,005
+13,644
| +50% | +$97.8K | ﹤0.01% | 2829 |
|
|
2024
Q1 | $236K | Buy |
27,361
+3,384
| +14% | +$29.2K | ﹤0.01% | 3248 |
|
|
2023
Q4 | $157K | Sell |
23,977
-235
| -1% | -$1.54K | ﹤0.01% | 3591 |
|
|
2023
Q3 | $241K | Buy |
24,212
+486
| +2% | +$4.84K | ﹤0.01% | 2945 |
|
|
2023
Q2 | $295K | Sell |
23,726
-15,010
| -39% | -$187K | ﹤0.01% | 2904 |
|
|
2023
Q1 | $543K | Buy |
38,736
+33,030
| +579% | +$463K | ﹤0.01% | 2587 |
|
|
2022
Q4 | $81K | Sell |
5,706
-4,891
| -46% | -$69.4K | ﹤0.01% | 3585 |
|
|
2022
Q3 | $270K | Buy |
10,597
+1,187
| +13% | +$30.2K | ﹤0.01% | 2927 |
|
|
2022
Q2 | $268K | Buy |
9,410
+4,519
| +92% | +$129K | ﹤0.01% | 2978 |
|
|
2022
Q1 | $172K | Buy |
+4,891
| New | +$172K | ﹤0.01% | 3401 |
|